ABSTRACT. We studied the interactions of corticosteroids, thyroid hormones, and @-agonist on surfactant phospholipids, pulmonary mechanics, and @-receptor binding in fetal lambs. We infused cortisol (450 pg/h for 48 h), thyrotropin-releasing hormone (TRH) (25 pg/h for 48 h), and ritodrine (1.3 pg/kg/min for 24 h) independently, and in double (cortisol plus @-agonist, cortisol plus TRH), and in triple (cortisol plus TRH plus @-agonist) combinations into chronically catheterized fetal lambs between 0.88 and 0.90 gestation. Infusion of the triple combination of cortisol plus TRH plus @-agonist resulted in a 20.9-fold increase in the saturated phosphatidylcholine content of fetal lung lavage, in a 5.8-fold increase in the saturated phosphatidylcholine content of whole fetal lung, and in a 13.3-fold increase in the saturated phosphatidylcholine content of fetal tracheal fluid. In addition, lung stability to inflation increased 3-fold, and lung stability to deflation increased 8-fold. The increases in the saturated phosphatidylcholine content of fetal lung lavage and tracheal fluid were greater than the effects of each hormone acting independently, or in the double combinations. The @-receptor maximal binding capacity was increased 30% by the combined infusion of cortisol and TRH. In addition, the maximal binding capacity after cortisol plus TRH plus @-agonist infusion was 54% greater than the maximal binding capacity after 8-agonist infusion. We conclude that the triple combination of cortisol, TRH, and P-agonist increases fetal lamb lung surfactant phospholipids better than do any of the hormones acting either independently, or in double combinations, and also improves pulmonary mechanics better than single hormones or the double combination of TRH and cortisol ( p < 0.01). We speculate that the interaction of cortisol and TRH enhances the capacity of the fetal lamb lung to respond to @-adrenergic stimulation, and that the triple combination of cortisol plus TRH plus @-agonist might prepare the fetal lung for air breathing more effectively than each of the hormones acting either independently, or In the double combinations. (Pediatr Res 24: 166-170,1988) Received January 4, 1988; accepted March 18, 1988 
ABSTRACT. We studied the interactions of corticosteroids, thyroid hormones, and @-agonist on surfactant phospholipids, pulmonary mechanics, and @-receptor binding in fetal lambs. We infused cortisol (450 pg/h for 48 h), thyrotropin-releasing hormone (TRH) (25 pg/h for 48 h), and ritodrine (1.3 pg/kg/min for 24 h) independently, and in double (cortisol plus @-agonist, cortisol plus TRH), and in triple (cortisol plus TRH plus @-agonist) combinations into chronically catheterized fetal lambs between 0.88 and 0.90 gestation. Infusion of the triple combination of cortisol plus TRH plus @-agonist resulted in a 20.9-fold increase in the saturated phosphatidylcholine content of fetal lung lavage, in a 5.8-fold increase in the saturated phosphatidylcholine content of whole fetal lung, and in a 13.3-fold increase in the saturated phosphatidylcholine content of fetal tracheal fluid. In addition, lung stability to inflation increased 3-fold, and lung stability to deflation increased 8-fold. The increases in the saturated phosphatidylcholine content of fetal lung lavage and tracheal fluid were greater than the effects of each hormone acting independently, or in the double combinations. The @-receptor maximal binding capacity was increased 30% by the combined infusion of cortisol and TRH. In addition, the maximal binding capacity after cortisol plus TRH plus @-agonist infusion was 54% greater than the maximal binding capacity after 8-agonist infusion. We conclude that the triple combination of cortisol, TRH, and P-agonist increases fetal lamb lung surfactant phospholipids better than do any of the hormones acting either independently, or in double combinations, and also improves pulmonary mechanics better than single hormones or the double combination of TRH and cortisol ( p < 0.01). We speculate that the interaction of cortisol and TRH enhances the capacity of the fetal lamb lung to respond to @-adrenergic stimulation, and that the triple combination of cortisol plus TRH plus @-agonist might prepare the fetal lung for air breathing more effectively than each of the hormones acting either independently, or In the double combinations. (Pediatr Res 24: 166-170,1988) Abbreviations Bmax, maximal binding capacity DHA, dihydroalprenolol K, dissociation constant RDS, respiratory distress syndrome SPC, saturated phosphatidylcholine TRH, thyrotropin-releasing hormone V40, lung volume at 40 cm water air inflation pressure V10, lung volume at 10 cm water air deflation pressure T4, thyroxine 1'3, tri-iodothyronine TTI, free thyroxine index PG, phosphatidylglycerol Since Liggins (1) first described glucocorticoid effects on fetal lamb lung in 1969, evidence has accumulated that the fetal lung is also responsive to other hormones, including thyroid hormones and P-agonists (2). Glucocorticoids and thyroid hormones act at different points in the pathways of surfactant phospholipid synthesis (2), whereas (3-agonists stimulate surfactant release and also regulate the production of fetal lung liquid (3). The maximal binding capacity of fetal lung preceptors is regulated by glucocorticoids (4) and thyroid hormones (5) .
Prenatal therapy with glucocorticoids reduces the incidence and severity of RDS, but is not always effective, especially in Caucasian male infants, in twins and after a short duration of therapy (6) . Prenatal exposure to 6-agonist has also been reported by Boog et al. (7) to decrease the incidence of RDS among premature infants. Recently Kwong and Egan (8) have reported that a combination of prenatal P-agonist and glucocorticoid therapy may be more effective than glucocorticoids alone in preventing RDS. Data from experimental systems suggest that thyroid hormones and glucocorticoids may also prove to be more effective in preventing RDS than glucocorticoids alone (2) . Ikegami et al. (9) have recently reported that the combination of glucocorticoids and thyroid hormones improves the response of premature rabbit lungs to treatment with exogenous surfactants.
We used the chronically catheterized fetal lamb to test the hypothesis that cortisol, TRH, and P-agonists have combined effects on the availability of surfactant in fetal airways, and on fetal lung stability to air inflation and deflation. In addition, we studied the combined effects of these hormones on the binding characteristics of P-receptors in fetal lamb lung. (10) and crown-rump measurements at delivery (1 1) were used to confirm the postconceptional ages provided by the supplier: they agreed within 3 days.
Nineteen ewes were operated on between 123 and 127 days gestation (term is 148 days in the sheep) under epidural anesthesia with 0.5% pontocaine as described previously (12) . Catheters were placed in a fetal carotid artery, jugular vein, and the trachea. The 1.5-mm internal diameter tracheal catheter was connected to a 600-ml latex bag which was left in the uterus. A separate exit catheter from the bag was exteriorized through the ewe's flank together with the fetal artery and vein catheters. After the operation, the mothers received 1.2 million U of procaine penicillin and 10 mg kanamycin, and were allowed to recover from the operation for 7 days.
The fetuses were assigned randomly to be controls (6) or to receive cortisol infusion (5), TRH infusion (4), P-agonist infusion (6), cortisol plus P-agonist infusion (6), cortisol plus TRH infusion (4), or cortisol plus TRH plus P-agonist infusion (5) .
Cortisol was infused intravenously at a rate of 450 g / h for 48 h. This rate of cortisol was chosen because it produces elevation of serum cortisol level (1 3) similar to those reported by Mescher et al. (14) in fetal lambs near term. TRH was infused intravenously at a rate of 25 pg/h for 48 h. This rate of TRH infusion was chosen because it produces significant stimulation of thyroid hormone production in fetal lambs (15) . The preferential (32-agonist Ritoclrine was infused intravenously at a rate of 1.3 + 0.3 hg/kg/min (mean + SD) for 24 h. This rate of Ritodrine infusion was chosen because it produces significant effects on tracheal fluid flow, surfactant, and pulmonary mechanics in fetal lambs (3) . The hormones were given in 0.9% saline solution as a vehicle at a rate of 4 ml/h. The controls received the saline infusion only.
A total of 2.5 ml of arterial blood (-1 % of fetal blood volume) was taken from the fetuses on the day before the start of the hormone infusions, on the day before death, and on the day of death. Arterial blood gases were measured at 39" C with a Corning blood gas analyzer (Corning Instruments, Corning, NY). Serum cortisol, T4, T3% uptake and FTI were measured by radioimmunoassay (Clinical Assays, Dade, Cambridge, MA).
Tracheal fluid was collected daily and stored at -20" C for subsequent analysis. The animals were killed between 130 and 134 days (0.88 to 0.90) gestation at the end of the hormone infusions with a rapid intravenous injection of sodium pentobarbital to the ewe and fetuses. The fetuses were immediately delivered from the uterus and the lungs were rapidly removed from the fetal thorax with clamping of the trachea to prevent egress of fetal lung fluid. The right upper lobe was cut into small pieces, rapidly frozen in liquid nitrogen, and stored at -70" C for subsequent analysis. The biochemical analyses reported below were stable for several months using this method of tissue preservation. The left lung was used to record air pressure-volume curves using a method similar to that of Gribetz et al. (16) . The V40 and the V10 were recorded. The left lung was then lavaged six or more times with a volume of saline equal to the V40 until a lavage volume of 280 ml had been collected. The proportion of the lavage volume recovered was 265%.
Lipids were extracted from the lung lavage, tracheal fluid, and from whole lung (17) , and the SPC content was measured with osmic acid (18) . The efficiency of the extraction of SPC was 291%, measured by recovery of a trace amount of 14C-SPC added before the extraction. The lipid extracts were also analyzed by thin-layer chromatography using the method of Touchstone et al. (19) . Lipids were expressed as mg/g wet weight of lung.
The wet to dry weight ratio ofthe lungs was assessed by heating weighed pieces of lung to dryness in an 80" C oven. The protein content of the lungs was determined by the method of Markwell et al. (20) and the DNA content was determined by the method of Erwin et al. ( 
1 ).
Beta-receptor binding assays for pulmonary membrane preparations were adapted from the methods described by Maniscalco and Shapiro (22) . Fetal pulmonary membranes were prepared and the P-receptor assays were performed using [3H]-DHA (New England Nuclear, Boston, MA) exactly as described previously by Warburton et al. (23) .
Four term fetal lambs (145 days, 0.99 gestation) and four newborn lambs were also killed with intravenous pentobarbital and the lungs were removed and processed as above for comparison with the premature fetal lambs.
The data are expressed as the mean f SD. Analysis of variance with the Newman-Kuel test was used to compare all the groups of lambs. Paired t test was used to assess the effects of cortisol and TRH infusions on serum cortisol and thyroid hormone levels both within fetuses and between treated fetuses and controls. Statistical significance was accepted with a p < 0.05.
RESULTS
The fetuses were killed between 130 and 134 days (0.88 to 0.90) gestation.
Fetal blood gases and hematocrit. Arterial blood gases in all the fetuses on the day before the hormone infusions were pH Fetal serum cortisol, T4, T3% uptake, andfree thyroxine index.
Cortisol infusion to the fetuses at a rate of 450 pg/h resulted in an increase in serum cortisol level from 2 to 4.2 k 0.2 mg/dl, p < 0.01. Cortisol infusion in combination with TRH and/or Pagonist resulted in a similar elevation of fetal serum cortisol level. TRH infusion to the fetuses at a rate of 25 ~g / h resulted in a 1.5-fold increase in fetal serum T4 level from 8.4 + 1.7 to 13.0 + 4.6 pg/ml, p < 0.05, a 1.2-fold increase in serum T3% uptake from 46.2 k 2.9 to 57.6 + 5.5%, p < 0.01, and a 1.9-fold increase in FTI from 10.9 f 2.2 to 20.5 + 6 . 5 ,~ < 0.01.
Lung protein, DNA, and wetldry weight. The protein content of the control fetal lungs was 32 + 6 mg/g wet weight, the DNA content was 2.7 f 0.1 pg/mg wet weight, the dry weight was 4.4 + 0.2 g and the wet/dry weight ratio was 0.107 + 0.006 (dry weight 10.7 f 0.6% of wet weight). Lung protein content, DNA, lung weight, and wet/dry weight were not altered by the infusion of cortisol, TRH, or P-agonist either independently, or in the double or triple combinations. The effects of the hormone infusions on tracheal fluid SPC content and SPC flux, on the SPC content of whole fetal lung, on the SPC and PG content of fetal lung lavage and on pulmonary mechanics are shown in Table 1. SPC content of trachealfluid. In comparison to the Bmax in cortisol plus TRH-infused fetuses, P-agonist infusion to fetuses previously treated with cortisol plus TRH decreased the Bmax by 50%. However, the Bmax was then 54% more than in fetuses receiving only (3-agonist infusion. The K i n the control fetuses was 3.4 + 0.6 mM and was not affected by hormone infusion.
DISCUSSION
The lung SPC content, lung lavage and tracheal fluid SPC and PG content, the V40 and the V10 in control fetuses are consistent with previously published reports of normal values for fetal lambs (24) . Lung protein, DNA, and wetldry weight ratio were also normal in controls, and were unchanged by the hormone treatments. The presence of the small (1.5 mm) bore tracheal catheter in this and previous experiments (23) did not affect lung growth, as reflected by lung wet weight, protein and DNA content, and dry weight.
Gestational age of the fetuses was carefully controlled in this study inasmuch as the period between 0.88 and 0.90 gestation is one of increasing maturity in controls. However, the hormonal effects we measured were significantly greater than the effects of normal fetal lung development between 0.88 and 0.90 gestation. In addition, the hormone infusions were given in random order to minimize possible seasonal or selection biases.
The numbers of fetuses in each group were too small to detect or exclude an effect of fetal gender on the response to hormone infusion. However, this may be important because male human infants do not always respond to glucocorticoid therapy (6) , and there is a female advantage in P-receptor maturation and surfactant development in fetal lambs (23) .
Infusion of cortisol resulted in elevation of fetal serum cortisol to levels similar to those reported previously from our laboratory (13) . These levels were similar to those reported to occur spontaneously by Mescher et al. (14) in catheterized control fetuses near term. The TRH infusion resulted in elevation of fetal serum thyroid hormone levels similar to those reported by Thomas et al. ( 1 5) after TRH infusion. The effects of P-agonist infusion on fetal arterial blood gases were also similar to those which we reported previously (3) . Fetal arterial blood gases were otherwise normal and were unaffected by the hormone infusions.
The independent effects of cortisol and @-agonists on surfactant phospholipids in tracheal fluid and lung lavage of fetal lambs were consistent with those reported previously by ourselves and others (3, 13, 25) . We reported recently that the inhibitory effects of ritodrine on lung liquid production could only account for 18% of the increase in surfactant recoverable in lung lavage (3) . Therefore a mere concentration effect could not explain the increase in lung lavage surfactant.
The SPC content of whole lung tissue does not distinguish specifically between surfactant-associated and membrane-associated pools of phospholipid, whereas postmortem lung lavage only provides an estimate of the alveolar surfactant pool in vivo.
However, the flux of surfactant SPC into the tracheal fluid of chronically catheterized fetal lambs has been used by several groups of investigators as a marker of pulmonary surfactant production (3, 13, 14, 25) . Taking the data on SPC content of whole lung and SPC and PG content of lung lavage together with the data on tracheal fluid content of SPC, we conclude that the triple combination of cortisol, TRH, and P-agonist enhances the availability of pulmonary surfactant phospholipid in the airways of the fetal lamb better than do any of the hormones acting either singly or in the double combinations.
Pulmonary mechanics measured as the stability of the lungs to inflation and deflation with air were also improved to a greater extent by the combination of cortisol plus TRH plus 6-agonist than by single hormone infusions or by the double combination of cortisol plus TRH. The increases in V10 are consistent with an increase in alveolar surfactant. However, the concomitant increases in V40 suggest that distensibility of the airways and interstitium also improved. Thinning out of the pulmonary interstitium after glucocorticoid treatment was among the original morphological observations of Liggins (1). Improved surfactant availability in the airways with enhanced stability of the Iung to inflation and deflation would be consistent with a decreased propensity to develop RDS in neonates.
We have recently shown that the onset of P-receptor maturation coincides with the appearance of surfactant in tracheal fluid in fetal lambs, and that the Bmax approximately doubles between 0.84 and 0.89 gestation (20) . The changes in Bmax reported here in response to hormone infusion were significantly greater than those reported in control fetal lambs during the same period of gestation. In the rabbit fetus, glucocorticoids increase the number of P-receptor binding sites (4) , whereas in the rat fetus hypothyroidism decreases the number of binding sites (5) . The lack of effect of corticosteroids alone on P-receptor binding capacity in the fetal lamb lung may be due either to a species difference or to the physiological concentrations of cortisol used herein in comparison with the pharmacological concentrations used in other systems (2).
Ballard (2) has suggested that both thyroid hormones and corticosteroids act directly in type I1 pneumocytes to induce different sets of gene sequences coding for different proteins. Thus, there would be overall additive or synergistic effects on surfactant phospholipid biosynthesis resulting in additive or synergistic effects on surfactant production. We speculate that the combination of cortisol and TRH induces components of the Padrenergic signal transduction system in fetal lamb lung so that the response to p-adrenergic stimulation is enhanced, in addition to any other possible effects on surfactant phospholipid synthesis.
We conclude that the triple combination of cortisol, TRH, and P-agonist increases fetal lamb lung surfactant phospholipids better than any of the hormones acting either independently, or in the double combinations we studied. Moreover, the triple combination of cortisol, TRH, and P-agonist improves fetal pulmonary mechanics better than any of the hormones acting independently, or the double combination of cortisol and TRH. We speculate that the triple combination of cortisol plus TRH plus P-agonist might prepare the fetal lung for air breathing more 170 WARBURTON ET AL effectively than each of the hormones acting either independently or in double combinations.
